Yayın:
Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone

Basit Görünüm
dc.contributor.buuauthorNak, Deniz
dc.contributor.buuauthorNak, Yavuz
dc.contributor.buuauthorSeyrek, Kamil İntaş
dc.contributor.buuauthorKumru, İsmail Hakkı
dc.contributor.departmentVeteriner Fakültesi
dc.contributor.departmentDoğum ve Ji̇nekoloji̇ Anabi̇li̇m Dalı
dc.contributor.researcheridAAH-7292-2019
dc.contributor.researcheridAAH-5494-2021
dc.contributor.scopusid9280090000
dc.contributor.scopusid8615464000
dc.contributor.scopusid6603409870
dc.contributor.scopusid16637505700
dc.date.accessioned2022-09-01T07:58:16Z
dc.date.available2022-09-01T07:58:16Z
dc.date.issued2004-12
dc.description.abstractA case of fibroadenomatous hyperplasia of the mammary gland in a nine-month-old female cat is reported. It was treated with medroxyprogesterone acetate for the suppression of oestrus. Two weeks later. hyperplasia occurred in all mammary glands. The progesterone receptor blocker aglepristone was given sc (10mg/kg) on days 1, 2 and 7. Mammary gland hyperplasia had completely regressed by day 21.
dc.identifier.citationNak, D. vd. (2004). “Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone”. Australian Veterinary Practitioner, 34(4), 161-162.
dc.identifier.endpage162
dc.identifier.issn0310-138X
dc.identifier.issue4
dc.identifier.scopus2-s2.0-13444256138
dc.identifier.startpage161
dc.identifier.urihttp://hdl.handle.net/11452/28415
dc.identifier.volume34
dc.identifier.wos000226461600005
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherAustralian Small Animal Veterinary Assoc
dc.relation.journalAustralian Veterinary Practitioner
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectVeterinary sciences
dc.subjectFelidae
dc.subjectFelis catus
dc.subject.emtreeArticle
dc.subject.emtreeBreast fibroadenoma
dc.subject.emtreeCat
dc.subject.emtreeControlled study
dc.subject.emtreeEstrus
dc.subject.emtreeFemale
dc.subject.emtreeNonhuman
dc.subject.emtreeTime series analysis
dc.subject.emtreeTreatment outcome
dc.subject.emtreeTumor regression
dc.subject.emtreeAglepristone
dc.subject.emtreeAntigestagen
dc.subject.emtreeMedroxyprogesterone acetate
dc.subject.emtreeUnclassified drug
dc.subject.scopusBreast Tumor; Experimental Mammary Neoplasms; Breast Neoplasms
dc.subject.wosVeterinary sciences
dc.titleTreatment of feline mammary fibroadenomatous hyperplasia with aglepristone
dc.typeArticle
dc.type.subtypeEditorial Material
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentVeteriner Fakültesi/Doğum ve Ji̇nekoloji̇ Anabi̇li̇m Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications